Sunday, January 20, 2019

Americans For Safe Access Activist Newsletter - January 2019


ASA Activist Newsletter

In the January 2019 Issue - The Year in Review

  • Federal Patient Protections included in 2018, Lapse in Shutdown
  • VA Medicinal Cannabis Research Act first out of committee since 1970
  • WHO Takes Rescheduling Steps with Input from ASA and FDA 
  • FDA Approves First Medicine Derived from Cannabis
  • After ASA Pressure, DEA Removes Online Lies
  • ASA Report on States Finds Improvement, EPNL Campaign Yields Changes 
  • Missouri Passes Medical Cannabis Amendment
  • Oklahoma Voters Approve Robust Medical Cannabis Program
  • Utah Adds Medical Cannabis by Initiative and Legislation
  • Pennsylvania and Virginia Expand Safe Access
  • ACTION ALERT: Contact Your Congressional Reps Today!

ASA in 2018: Protecting Patients, Expanding Access, Creating AlliancesASA Year in Review

For Americans for Safe Access, 2018 was a year of solidifying gains, pushing boundaries and finding allies for medical cannabis patients.
In the beginning of 2018, patients faced considerable uncertainty. The attorney general removed boundaries on medical cannabis prosecution put in place by the Obama administration, and the House of Representatives was blocked from voting on the funding amendment that had prevented federal interference in state programs since 2014.
Steph Sherer at the U.S. CapitolDespite that, lobbying by patient advocates helped get the Rohrabacher-Blumenauer Amendment included in the 2018 omnibus spending bill, and the representative responsible for blocking it in the House has now been voted out of office. Even better, the Appropriations Committee included the protective language in the actual appropriations bill for 2019, so it would not have to be added by amendment.
ASA efforts to reform Veterans Administration policy resulted in the VA Medicinal Cannabis Research Act of 2018, which ASA successfully lobbied to expand research opportunities and prevent the exclusion of victims of the War on Drugs. This piece of legislation became the first cannabis bill to pass out of committee since 1970.
Confronting the opioid crisis head on, ASA redoubled efforts to make sure that people living with pain have access to medical cannabis. ASA’s report, Medical Cannabis as a Tool to Combat Pain and the Opioid Crisis: A Blueprint for State Policy, was distributed at the 2018 National Conference of State Legislatures, and ASA recommendations were adopted by New York, Pennsylvania and Illinois. ASA expertise has influenced program expansions in states such as Virginia. ASA staff have been deeply involved in pushing implementation of Guam’s medical cannabis program, at the request of local advocates.
ASA forged new alliances and strategic partnerships. Work with international standards and scientific research organizations has helped advance common benchmarks for testing and safety. New connections with other patient groups such as Disabled American Veterans, The American Legion, The Abilities Expo, The National Pain Foundation, and The Michael J Fox Foundation has helped reach patients who might not be aware that medical cannabis could help.
________________________

Federal Protections for Medical Cannabis Included in 2018, Lapse in Shutdown

In 2018, federal protections for state medical cannabis programs and the individuals who participate in them were again extended through an annual appropriations amendment. After years of citizen lobbying by ASA and other patient advocates, the amendment was first included in the 2014 appropriations bill that funds the Department of Justice (DOJ).
The current government shutdown over the federal budget means a lapse in the restriction that prevents the DOJ from spending any funds interfering with state programs. Federal prosecutions of state-compliant individuals is at the discretion of each of the U.S. Attorney's offices. The amendment language has been included in the continuing resolutions offered that would reopen the government extending the 2018 funding bill to a future date.

VA Medicinal Cannabis Research Act first out of committee since 1970

In 2018, ASA also helped break a 48-year Congressional impasse, as the first piece of actual legislation on cannabis passed out of a committee. The VA Medicinal Cannabis Research Act of 2018, which would have tasked the Veterans Health Administration with investigating medical use, was passed out of the House Committee on Veterans Affairs on a unanimous vote. It was not enacted, but the new congress has already seen the introduction of bipartisan bills to de-schedule cannabis and otherwise address the conflict between federal prohibition and state cannabis laws.
________________________

U.S. Certification Program Joins Forces with International Standards Group


The cannabis industry will benefit from a new partnership between researchers and a that will produce guidance for everything from cannabis cultivation to cosmetics.

The global standards organization American Society for Testing and Materials (ASTM International) is partnering with researchers at the International Cannabis and Cannabinoids Institute (ICCI). ICCI, located in the Czech Republic and cofounded by ASA, is the first European partner for ASTM International’s cannabis committee, which includes businesses, laboratories, associations, and governments.
________________________

World Health Organization Takes First Steps to Reschedule Cannabis


After testimony and evidence presented by ASA and other members of the International Medical Cannabis Patients Coalition (IMCPC), the head of the World Health Organization (WHO) notified the United Nations that cannabidiol (CBD) is so safe it does not need legal controls.
The WHO also notified the UN that the experts found evidence that cannabis, THC, and extracts do not fit the current, highly restrictive classification, so they conducted a “critical review” of those in November, the first every done by the WHO or the UN. The results of that review have been withheld.
ASA and IMCPC submitted four reports on cannabis and its components to the WHO’s Expert Committee on Drug Dependence (ECDD). In response to a request from the U.S. Food and Drug Administration last April, ASA also submitted comments on the medical efficacy and safety of cannabis in support of the WHO review of cannabis. Patient advocacy groups from Argentina, Mexico, Uruguay, France, Germany, New Zealand, the Netherlands, South Africa, and the United States all recommended changes in the international scheduling of cannabis and medical products made from it.
More Information
Response to Pre-review: delta-9-tetrahydrocannabinol
Response to Pre-review: Extracts and tinctures of cannabis
Response to Critical Review: Cannabidiol
Response to Pre-review: Cannabis plant and resin
________________________

FDA Approves First Medicine Derived from Cannabis

In a milestone decision, the Food and Drug Administration (FDA) in September, 2018 approved for the first time a medication derived from the cannabis plant. Epidiolex, an oral solution of cannabidiol (CBD) developed by GW Pharmaceuticals, has been approved for the treatment of two rare seizure disorders, Dravet syndrome and Lennox-Gastaut syndrome. It is the first FDA-approved treatment for Dravet syndrome.
FDA logo
In late September, the Drug Enforcement Administration (DEA) placed Epidiolex in Schedule V, the least restrictive category. The FDA noted in its recommendation to the DEA that CBD products “do not have a significant potential for abuse and could be removed from the CSA.” Cannabis and its constituents, including CBD, remain illegal under federal law as Schedule I substances.
FDA-approved medications can be prescribed by doctors, purchased in pharmacies, and typically covered by insurance. Epidiolex costs approximately $2,750 per month.
________________________

After ASA Pressure, DEA Removes Online Lies

Following a formal request from ASA and an online petition that surpassed 100,000 signatures, the Drug Enforcement Administration (DEA) early last year removed misinformation about the health effects of medical cannabis from its website. The petition, filed with pro bono legal assistance from the law firm Orrick, was ostensibly denied in a letter dated January 26th, but the DEA removed 23 of the 25 factual inaccuracies ASA challenged and corrected the other two. For years, the DEA has published incomplete and inaccurate information about the health effects of medical cannabis. ASA’s petition noted that the DEA has directly contradicted much of this misinformation in recent public statements. ASA argued that the information required correction because Congress relies on the DEA for tools to make informed decisions about public health.
________________________

New State Programs and Expanded Access for Medical Cannabis 


Improvements in state medical cannabis programs were identified in ASA’s fourth annual report, released at the start of 2018. The comprehensive report, Medical Marijuana Access in the United States: A Patient-Focused Analysis of the Patchwork of State Laws, graded existing state laws and regulations and laws based on such factors as how easily patients can navigate the program, what type of access to medicine is available and what civil protections for patients are provided, as well as consumer safety and the overall functionality of the system. Many states showed improvements from previous years, with seven states scoring a “B+” -- more than double the number from the year. State developments in 2018 will be included in the next annual report, due out next month, but there were several significant developments, including the new and improved programs in Missouri, Oklahoma, Utah, Pennsylvania and Virginia described below:

Missouri Voters Add Medical Cannabis to Constitution

In Missouri three medical cannabis initiatives were on the ballot, with Amendment 2 winning out with 65.5%. The constitutional amendment allows patients to register as of July 4. Patients will be allowed up to four ounces. Qualifying conditions are broadly defined and up to 192 dispensaries are to be licensed throughout Missouri. State officials say the soonest medical cannabis dispensaries will be serving patients is January 2020. Because the new law is a constitutional amendment, any changes to it would need to pass in the Missouri legislature then be put to a public vote.

Oklahoma Voters Enact Robust Medical Cannabis Program

Oklahoma flagIn a June primary election, 57% of Oklahoma voters approved a medical cannabis initiative establishing one of the most robust safe access programs in the U.S. The initiative attracted nearly 41,000 more votes than all primary candidates for governor combined. Implementation has been rapid. Six months since passage, there are more than 22,000 registered patients and 785 licensed dispensaries. The initiative reflects a number of patient-focused principals from ASA’s model legislation, including strong civil protections, reasonable possession amounts, and a right to personal cultivation.  

Utah Medical Cannabis Initiative Passes, Gets Replaced by Bill

Utah voters passed a medical cannabis initiative Proposition 2 with nearly 53% of the vote. But Utah state law allows citizen initiatives to be overridden by the legislature, and before Proposition 2 could go into effect, state lawmakers replaced it with a more restrictive alternative bill. The Utah Medical Cannabis Act was touted as a “compromise bill” but included limited input from patient advocates. The action was part of a special session called by the governor. The new law creates a complex distribution system with a state-run “central fill pharmacy” and 10-15 cultivators. The legislation removed most autoimmune diseases from the list of qualifying conditions, except for Crohn’s disease and ulcerative colitis. Patient registrations will be valid for just 30 days, then subject to renewal every six months.

Pennsylvania Expands Qualifying Products and Conditions

PA flagIn line with ASA recommendations, Pennsylvania lawmakers last year added four new medical conditions and approved the use of whole-plant cannabis products that can be vaporized. Access to whole-plant cannabis should lower costs for patients, who were limited to more expensive highly processed forms. Added to qualifying conditions are spasticity, cancer remission therapy, neurodegenerative disorders, and opioid addiction therapy. ASA’s End Pain, Not Lives campaign has been working to persuade policy makers to make cannabis available as an alternative to opioid medications.

Virginia Advocates Help Pave Way to Program Expansion

VA flagThe Virginia House of Delegates and Senate unanimously passed bills last February to expand the commonwealth’s restrictive medical cannabis law. The bills expand what was a very restrictive law to any condition a patient’s physician approves.  The change was the result of tireless lobbying by Virginia patient advocates, including ASA staff who live in the state. Those efforts resulted in not a single lawmaker opposing the bills either in committee or floor votes.
________________________

Upcoming ASA Events

End Pain, Not Lives Fundraiser/Networking Event – January 25, 2019


On January 25, please join ASA for a fundraiser and networking event for the “End Pain, Not Lives” national campaign to raise awareness about alternatives to opioids. Everyone is welcome. Spread the word by sharing the link on social media and inviting friends to attend the event. Space is limited, so buy your tickets soon to secure a spot. If you cannot attend in person, but still want to give, please choose the donate-only ticket option. A list of donor names will be shown at the event. For sponsorship information, please contact Reenal@safeaccessnow.org.

Unity 2019 Conference  – March 18-20, 2019

Early Bird Registration is still open for ASA’s 2019 National Medical Cannabis Unity Conference. The 7th annual conference will be held next year in Washington, D.C. from March 18-20. The theme for 2019 is “The Price of Being a Medical Cannabis Patient," with panels on the financial and social barriers patients face. If you are interested in helping sponsor the conference, please visit our sponsorship page or contact ASA via email at conference@safeaccessnow.org to help support Unity 2019. To register and find out more, go to http://www.nationalmedicalcannabisunityconference.org/
________________________

ACTION ALERT: Contact Your Congressional Reps Today

A new Congress means you may have new congressional representatives working in Washington, DC. Do you know where your Senators and Representative stand on medical cannabis? What are they going to do to protect medical cannabis? Bipartisan bills to support research and safe access are already being introduced. Use ASA's easy online tool to ask them to support safe access today! www.safeaccessnow.org/newcongress.
________________________

Friday, January 18, 2019

Call To Action: End the Discrimination. Allow Medical Cannabis in Schools.

Image result for medical cannabis in schools

Today, Friday January 18th 2019, the New Mexico State Legislature has taken the day off in it’s limited 60-Day Session. Today there are also kids who can not go to school, despite how much they want to go to school.

We have kids facing discrimination at the hands of public school administrators in New Mexico because they are medical cannabis patients using a life saving medicine. A bill filed for the 2019 legislative session would allow students, who are participants in the state’s medical cannabis program, to access the medicine while at school.

Republican Senator Candace Gould authored Senate Bill 204, Titled ‘Medical Marijuana in Schools’. Senator Gould told KOB 4 that, the bill attempts to balance protecting schools and protecting rights of New Mexican families.

This legislation should be a priority and our lawmakers should give it the priority designation this legislation deserves. The Governor and the leadership in the Legislature have known for over 6 months and have continued to allow this discrimination to happen to these students.

The Governor’s Office can end this discrimination today, that these kids are facing at the hands of New Mexico Public School Administrators with a Executive Order. Following the filing of the legislation, Safe Access New Mexico and parents of the student who are pediatric patients did put several requests into the Governor's Office to do a Executive Order or to fast track this in the legislature and they reached out to Lt. Governor Howie Morales, as well.

Anthony, Paloma and all the kids/students this affects deserve to be able to get back to school as soon as possible. It’s just like Governor Lujan Grisham said about New Mexico state government in her first inaugural address on January 1st 2019; “There is no more time to lose.” and that “We will do things the right way again”.


Lindsay and Paloma Credit: ABQ Journal         Tisha and Anthony Credit: KOB 4 

The Governor’s Office and the Lt. Governor’s Office have yet to respond to Ms. Brick and her meeting request nor have they responded to Safe Access New Mexico.

These kids are losing time, time they will not get back, while waiting for the State to end this discrimination.

California, New York, Virginia and Washington all have joined New Mexico in having active 2019 Legislation for Allowing Safe Access to Medical Cannabis in School.

Currently there are seven other states and one capital city with comprehensive medical cannabis programs that allow medical cannabis in schools: Oklahoma City and these states; New Jersey, Maine, Washington, Colorado, Pennsylvania, Florida, Illinois.

All have successfully set forth rules and regulations for allowing safe access to medical cannabis while attending public schools.

No school or school district in the US has ever lost any federal funding for allowing safe access to medical cannabis at school, nor has there been any problems.


Here is what You can do to help advocate for the passage of this Legislation:
Please do a nice Email and/or Write a letter, and Call your New Mexico Legislators for Senate Bill 204, Titled ‘Medical Marijuana in Schools’, asking for support and quick legislative action on it. 

Link Here: https://www.nmlegis.gov/Members/Find_My_Legislator

Please do a nice Email and/or Write a letter, and Call the Leadership in the Legislature and ask the Speaker of the House (Mr. Brian Egolf) and President Pro Tempore of the Senate (Ms. Mary Kay Papen) for quick legislative action on Senate Bill 204, Titled ‘Medical Marijuana in Schools’.
Link Leadership Here: https://www.nmlegis.gov/Members/Leadership

Send the Governor an Email on the Governor’s Website Contact Form and place a Phone Call asking for Governor Lujan Grisham to do a Executive Order and for quick legislative action on Senate Bill 204, Titled ‘Medical Marijuana in Schools’.
Governor’s Office Phone: (505) 476-2200
Link Here: https://www.governor.state.nm.us/contact/

Call Lt. Governor Howie Morales’ Office and ask him to support doing a Executive Order and/or quick legislative action on Senate Bill 204, Titled ‘Medical Marijuana in Schools’: (505) 476-2250


“Section 2. PURPOSE OF ACT.—The purpose of the Lynn and Erin Compassionate Use Act is to allow the beneficial use of medical cannabis in a regulated system for alleviating symptoms caused by debilitating medical conditions and their medical treatments.”

These courageous mothers united at the Roundhouse, fearlessly advocating for patients’ rights and safe access for the beneficial use of medical cannabis in schools on October 25th 2018. Now we, the medical cannabis community and advocates need to Unite for them in advocating for the support and passage of this new law!

Image result for medical cannabis in schools

Wednesday, January 16, 2019

Any Health Condition Opioids Are Prescribed For Are Already Part Of New Mexico’s Medical Cannabis Program



Right now children who are medical cannabis patients are being discriminated against by the New Mexico Public School System, Period.

Since yesterday’s State of the State address, all we have heard about on the news and in the newspapers is how the Democratically controlled legislature wants Recreational Cannabis Use Legalization to be a priority in the Legislative Session and our new Governor wanting to add a health condition into the medical cannabis program, Opioid Use Disorder, that is already being treated in the medical cannabis program (MCP). Any health condition a doctor would prescribe opioids for are already part of New Mexico’s Medical Cannabis Program.[6,7,11]

If Governor Lujan Grisham had talked to any of the Doctors on the State’s Medical Cannabis Advisory Board, then the Governor would understand this and the same would be true if Governor Lujan Grisham attended any of the Medical Cannabis Advisory Hearings she was invited to attend while campaigning to be our Governor. Prior to the Advisory Board Hearings, Mr. Victor Reyes was contacted for those invites and acknowledged the invitations, he is now part of the Legislative Policy team in the Governor's Office.

“Opioid addiction is an epidemic that is tearing New Mexico families apart. As my third Leadership in Action Initiative, I will immediately direct the Department of Health to add opioid addiction as a condition to qualify for medical cannabis treatment.” [1]

[1]

The key word in the Governor’s statement is "Addiction", and that is what is really being treated if this is added, not opioid misuse or abuse. Our state's medical cannabis program already covers all health conditions that opioids are prescribed for.[6,7,11]

As many do not realize, the Chronic Pain health condition is a ‘umbrella term’ covering well over 200 different health conditions that do qualify for enrollment into the medical cannabis program.
“In most cases, the board said, patients who suffer from the rejected conditions are already able to be certified to use cannabis under an existing qualifying condition — such as chronic pain…”[6,7] Medical Cannabis Program Director, Kenny Vigil even points out that, “In five years, no patient has been denied a card.”[8]

[4]

Adding Opioid Use Disorder will only allow limit safe access to treatment while ignoring the true addiction problem and other addicts entirely, ignoring those who deal with Alcohol Use Disorder (AUD), Tobacco Use Disorder, Stimulant Use Disorder, or Hallucinogen Use Disorder - that is not the true approach to harm reduction.

According to the Mayo Clinic and Substance Abuse and Mental Health Services Administration; the known risk factors of opioid misuse and addiction include: Family history of substance abuse, Personal history of substance abuse, Heavy tobacco use, and Heavy alcohol use. The key word in the Governor’s statement is "Addiction", and that is what is really being treated.

The inclusion of a new medical condition into the New Mexico Medical Cannabis Program should be, Substance Abuse Disorder. When Doctors on the State’s Medical Cannabis Advisory Board considered and voted on both petitions to add Opioid Use Disorder and Substance Abuse Disorder into the program, they said that “addiction” is being treated by both Petitions and that it makes most sense to add Substance Abuse into the State’s Medical Cannabis Program. 
We should be Ending Pain Not Lives in New Mexico and that is done by adding Substance Abuse Disorder[2] into the Medical Cannabis Program.

Governor Lujan Grisham should be listening to these medical experts and the policy experts at Americans For Safe Access.

Additionally, before any new health condition(s) are added into the MCP that would lead to a rapid increase of new patients, "adequate supply" needs to be addressed and fixed. As of right now there is less than 1/3 of a cannabis plant available per patient as medicine. State District Judge David Thomson in Santa Fe, already issued a court ruling telling the State this must be done and the State has yet to follow the Judge’s orders.[10]

The state must increase the plant count before a health condition is added that would cause a rapid increase in program participants otherwise there be a shortage in medicine available.

It makes absolutely no sense to add a new health condition involving addiction, if there is any chance that program participants may end up going to the black market for cannabis since the State isn’t following the Purpose of its own medical cannabis law.

Governor Lujan Grisham should be first and foremost be talking about fixing the medical cannabis program to allow Safe Access to Medical Cannabis at Schools and end the discrimination there.

 [9]

“Lujan Grisham said she supports the medicine on school grounds as long as safety and administrative standards are established.
“For many students their ability to use medical cannabis on school grounds is the difference between being able to attend public school or not,” she wrote to the Journal.”[3]

In 2019 during the Legislative 60 day Regular Session Please : Pass a bill to Fix & Expand the states Neglected Medical Cannabis Program, Pass a bill Allowing Safe Access to Medical Cannabis at Schools, Enable Veterinary Doctors access to the Medical Cannabis Program, Pass Decriminalization of Cannabis for the State, Pass Medical Cannabis Research for UNM and get the Industrial Hemp program going with medical hemp research at NMSU for the states medical cannabis program.
These proposed measures will also generate additional revenue and jobs for the State.

Build a solid foundation first.
Then start talking about Recreational Cannabis Use Legalization.

In the recent Albuquerque Journal 5 Part Article Series, “Legal Pot or Not?”, Duke Rodriguez the owner of the state licensed medical cannabis dispensary, Ultra Health, says this in the Day 4 article about our newly elected Governor; “Generally, opponents of adult use will cry that the medical cannabis programs will be harmed,” Rodriguez said. “The reality is that states with mature medical cannabis systems have rolled out adult use programs without harming the medical program.”[4]

In response to this quote by Governor Lujan Grisham; “Gov. Michelle Lujan Grisham says she supports legalized recreational marijuana – with important caveats.
She said on the campaign trail and in a statement to the Journal that any legislation reaching her desk would have to “protect medical cannabis patients, improve public safety, deal with prevention of underage use and workplace impairment, boost state revenues, and allow for New Mexico businesses to grow into this new market during an effective transition period.”[5]


Legislators in the Roundhouse are projected to have $1.2 billion coming in for the new budget year, so there is absolutely no need to fast track recreational cannabis legalization in New Mexico for 2019.

First and Foremost these lawmakers MUST keep Medical and Recreational separate in ALL Legislation- The legalization of cannabis for recreational use is a separate issue from safe and legal access to cannabis for therapeutic use. We caution policy makers against letting the debate surrounding legalization of cannabis for recreational use obscure the science and policy regarding the medical use of cannabis.

Today the New Mexico Medical Cannabis Program has over 70,000 registered participants with over 75 dispensaries operated by 35 licensed non-profit producers (LNPP’s) now growing 14,550 cannabis plants. The Medical Cannabis Program (MCP) was created in 2007, as the Lynn and Erin Compassionate Use Act, under chapter 210 Senate Bill 523. New Mexico’s medical cannabis history started in 1978, after public hearings the legislature enacted H.B. 329, the nation’s first law recognizing the medical value of cannabis…the first law.

“Section 2. PURPOSE OF ACT.—The purpose of the Lynn and Erin Compassionate Use Act is to allow the beneficial use of medical cannabis in a regulated system for alleviating symptoms caused by debilitating medical conditions and their medical treatments.”

The Governor’s Office can end this discrimination today, that these kids are facing at the hands of New Mexico Public School Administrators with a Executive Order. As requested in the Governor’s first week in Office by Safe Access New Mexico and Ms. Brick, a parent of one of theses students being discriminated against. It’s just like Governor Lujan Grisham said about New Mexico state government in her first inaugural address on January 1st 2019; “There is no more time to lose.” and that “We will do things the right way again”. 

Image result for tisha brick kob
Lindsay and Paloma Credit: ABQ Journal Tisha and Anthony Credit: KOB 4

The Governor’s Office has yet to respond to Ms. Brick or Safe Access New Mexico and these kids are losing time, time they will not get back, while waiting for the “right way” to happen. 

California, New York, Virginia and Washington all have joined New Mexico in having active 2019 Legislation for Allowing Safe Access to Medical Cannabis in School.

Currently there are seven other states and one capital city with comprehensive medical cannabis programs: Oklahoma City and these states; New Jersey, Maine, Washington, Colorado, Pennsylvania, Florida,  Illinois. All have successfully set forth rules and regulations for allowing safe access to medical cannabis while attending public schools. 
No school or school district in the US has ever lost any federal funding for allowing safe access to medical cannabis at school, nor has there been any problems.



Resources/Sources:
[1]https://www.facebook.com/mlujangrisham/videos/690062724711554/
[2]http://lecuanmmcpmcabpetitions.blogspot.com/2017/09/petition-substance-abuse-disorder.html
[3]https://www.abqjournal.com/1240091/gov-candidates-disagree-on-parcc-other-education-issues.html
[4]https://www.abqjournal.com/1266098/legal-pot-or-not-protecting-nms-medical-marijuana-industry.html
[5]https://www.abqjournal.com/1266533/passage-hinges-on-a-few-senate-democrats.html
[6]http://www.santafenewmexican.com/news/health_and_science/cannabis-advisory-board-recommends-adding-qualifying-ailments/article_99ffb468-a82d-5363-bbf8-b540521edf86.html
[7]http://www.santafenewmexican.com/news/local_news/advisory-panel-backs-opioid-use-disorder-as-qualifying-condition-for/article_4619cdf7-df7d-5db4-959f-97217c971fe3.html
[8]https://www.abqjournal.com/1266099/growing-the-program-ex-ptsd-chronic-severe-pain-among-14-medical-conditions-added-to-eligible-diagnoses.html
[9]https://www.krqe.com/news/new-mexico/mothers-rally-at-roundhouse-to-allow-medical-cannabis-in-schools/1550365486
[10]http://www.cannabisnewsjournal.co/2018/11/new-mexico-medical-cannabis-program.html
[11]https://nmhealth.org/about/mcp/svcs/
New Mexico’s Medical Cannabis Program Qualifying Health Condition List(22):
  1. Amyotrophic Lateral Sclerosis (ALS)
  2. Cancer (specify type in clinical notes)
  3. Crohn’s Disease
  4. Epilepsy/Seizure Disorders
  5. Glaucoma
  6. HCV infection and receiving antiviral treatment currently (proof of antiviral treatment in clinical notes)
  7. HIV/AIDS
  8. Huntington’s Disease
  9. Hospice Care
  10. Inclusion Body Myositis
  11. Inflammatory autoimmune-mediated arthritis
  12. Intractable Nausea/Vomiting
  13. Multiple Sclerosis
  14. Damage to the nervous tissue of the spinal cord (provide proof of objective neurological indication of intractable spasticity in clinical notes)
  15. Obstructive Sleep Apnea
  16. Painful Peripheral Neuropathy
  17. Parkinson’s Disease
  18. Post‐Traumatic Stress Disorder
  19. Severe Chronic Pain
  20. Severe Anorexia/Cachexia
  21. Spasmodic Torticollis (Cervical Dystonia)
  22. Ulcerative Colitis

ASA’s Resources for Regulators, Policy Makers, Medical Professionals & Researchers:Medical Professionals /Researchers
https://www.safeaccessnow.org/medical_professionals
Policy Makers / Regulators
https://www.safeaccessnow.org/policy_shop

Tuesday, January 15, 2019

DEA Museum Exhibit Targets New Mexico During Cannabis Legalization Debate

Image result for dea museum coming to albuquerque

"Drugs: Costs & Consequences" is a traveling exhibition from the United States Drug Enforcement Administration (DEA) Museum and the DEA Education Foundation. Formerly known as Target America, the exhibition has traveled to 16 cities and has been viewed by more than 22 million visitors. 

The DEA has timed the exhibit be on display in Albuquerque at the sametime the State's Legislature is to be debating proposed legislation to legalize recreational cannabis use in New Mexico.  The exhibit will be open daily in Albuquerque from January 26 through September 30, 2019.  

Margie Marino, director of the New Mexico Museum of Natural History & Science said, "the DEA drug exhibition provides a very powerful message on the destructive impacts of drug use in our society, on families, health, our environment and community safety”. “As the depth and breadth of this epidemic has come into focus in New Mexico, the museum was eager to partner with the DEA and our many engaged local partners to lay bare the heinous impact these drugs are having on our society,” said Marino.

The Natural History Museum's website says, as with past exhibits, the “Drugs” exhibition aims to connect with a broad group of organizations in the local community. These organizations represent the private sector, non-profit organizations, schools/school systems, law enforcement, federal agencies, state agencies, medical fields, prevention and treatment organizations, faith-based organizations, and others.


Related image

The DEA Task Force has meet three times in Albuquerque to date and will continue to meet throughout the duration of the exhibition. The Task Force is establishing a speakers list as a resource for local media and working to create a community event for those impacted by addiction and will facilitate a space near the exhibit where people can share their stories.  

The Substance Abuse and Mental Health Services Division (SAMHSA) of the United States Drug Enforcement Administration will reimburse transportation costs for student field trips to the upcoming exhibition Drugs: Costs & Consequences: Opening Eyes to the Damage Drugs Cause at the New Mexico Museum of Natural History & Science. 


“We want as many New Mexico middle & high school students as possible to see this eye-opening exhibition about the devastating costs of addiction in the hope that this experience will prevent future drug use, encourage drug users to seek help, and ultimately prevent future deaths from drug abuse,” said Margie Marino, Director of the New Mexico Museum of Natural History & Science (NMMNHS).


“The reimbursement costs will be applicable to  groups of students in the 4th grade and beyond,” Marino said.

Related image

As part of the exhibition contract, the Drug Enforcement Administration will contribute up to $40,000 in funds to reimburse transportation costs for student bus trips. The exhibit is broken into categories such as “The Cost of Drugs,” “Drugs and the Body,” “Drugs and the Environment” and “Breaking the Cycle.” The DEA also runs its online program “Drugs 360” through the Albuquerque Public Schools.

Contact your Child's school to find out if they will be taken to see this "reefer madness" style exhibit, as the DEA customizes each exhibition in each state to target certain policy topics, like legalization of cannabis.